https://www.selleckchem.com/pr....oducts/vps34-in1.htm
This study aims to genomically characterize melanoma of unknown primary (MUP) in comparison to melanomas of cutaneous primary (MCP). Eligible cases were collected from the MSK-IMPACT™ Clinical Sequencing Cohort published in the cBioPortal database. Genomic analysis was performed using a hybridization-capture-based next-generation sequencing assay designed to detect mutations, small insertions and deletions, copy number alterations, and genomic rearrangements. Among 462 patients of whom 18.4% had MUP, brain metastasis was more common a
Like
Comment
Share
